BridgeMD
New treatment option for Post Traumatic Stress Disorder
Official title A Pilot Study of Trauma-Focused Cognitive-Behavioral Therapy for Treatment of Post-traumatic Stress in Adults.
ClinicalTrials.gov ID: NCT06516874
What this study is testing
- What it's testing
- Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by the experience of potentially traumatic events. Complex PTSD (CPTSD) includes additional symptoms that account for a disturbance of the organization of the self.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- Eligibility criteria:
- Men and women over 18 years of age.
- Referred to a community mental health care service (CMHCS) or hospital in the Maule Region for difficulties associated with the experience of...
- Not being treated for PTSD or C-PTSD at the time of recruitment
- Men and women over 18 years of age.
You likely can't join if
- Previously or currently diagnosed psychotic disorder.
- Current substance use disorder.
- Current suicidal crisis.
- Depression is the primary diagnosis.
- Participation in a PTSD psychological treatment parallel to the study. Study's exit criteria:
- Initiation of a psychological or pharmacological treatment for PTSD parallel to the study.
See the full eligibility criteria
- Eligibility criteria:
- Men and women over 18 years of age.
- Referred to a community mental health care service (CMHCS) or hospital in the Maule Region for difficulties associated with the experience of traumatic events, symptomatology, or diagnosis of Post-Traumatic Stress...
- Not being treated for PTSD or C-PTSD at the time of recruitment
- Men and women over 18 years of age.
- Referred to a community mental health care service (CMHCS) or hospital in the Maule Region for difficulties associated with the experience of traumatic events, symptomatology, or diagnosis of Post-Traumatic Stress...
- Having the diagnosis of Post-Traumatic Stress Disorder (PTSD) or Complex Post-Traumatic Stress Disorder (CPTSD) by International Trauma Interview (ITI).
- Fluent in oral and written Spanish language.
- Access to telephone.
- Previously or currently diagnosed psychotic disorder.
- Current substance use disorder.
- Current suicidal crisis.
- Depression is the primary diagnosis.
- Participation in a PTSD psychological treatment parallel to the study. Study's exit criteria:
- Initiation of a psychological or pharmacological treatment for PTSD parallel to the study.
- Change of medication dose in the case of participants with pharmacological treatment prior to the study.
The study team makes the final eligibility decision.
Where it's taking place
- Curicó, Maule Region, Chile
- Linares, Maule Region, Chile
- Maule, Maule Region, Chile
- Talca, Maule Region, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Curicó, Maule Region, Chile; Linares, Maule Region, Chile; Maule, Maule Region, Chile; Talca, Maule Region, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.